Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.

Area of Science:

• Mitochondrial biology
• Immunology
• Genetics

Background:

• Nicotinamide nucleotide transhydrogenase (NNT) is a mitochondrial enzyme crucial for NADPH synthesis and immune response regulation.
• NNT-antisense 1 (NNT-AS1), a long non-coding RNA, is transcribed from the NNT locus and exhibits anti-proliferative effects.

Purpose of the Study:

• To investigate the expression levels of NNT and NNT-AS1 in peripheral blood of relapsing-remitting multiple sclerosis (MS) patients.
• To determine the correlation between NNT and NNT-AS1 expression and clinical parameters like age and sex in MS patients and healthy controls.

Main Methods:

• Quantitative analysis of NNT and NNT-AS1 expression in 50 MS patients and healthy controls.
• Statistical analysis including quantile regression and adjustment for age and sex effects.
• Assessment of pairwise correlations between NNT and NNT-AS1 transcript levels.

Main Results:

• A significant difference in NNT expression was observed only in male MS patients over 50 years old compared to controls.
• No significant difference in NNT-AS1 expression was found between MS patients and controls after adjusting for age and sex.
• NNT and NNT-AS1 expressions correlated with age in controls and female subjects, respectively.

Conclusions:

• NNT plays a gender-specific role in the pathogenesis of multiple sclerosis.
• Significant pairwise correlations exist between NNT and NNT-AS1 transcript levels in both MS patients and controls.